1940
C. Shen et al. / Tetrahedron: Asymmetry 21 (2010) 1936–1941
4.2.7. Benzyl-4,6-O-benzylidene-2-deoxy-2-(3-nitroben-
4.3.4. Benzyl-4,6-O-benzylidene-3-O-(diphenylphosphino)-2-
zylideneamino)-
a
-
D
-glucoside 9g
deoxy-2-(4-nitrobenzylideneamino)-a-D-glucoside 10d
Yield (1 mmol, 0.470 g, 96%). ½a D20
ꢁ
¼ þ5:3 (c 0.50, CHCl3); 1H
Yield (0.5 mmol, 310 g, 92%). ½a D20
ꢁ
¼ þ21:4 (c 0.39, CHCl3); 1H
NMR (400 MHz, CDCl3): d 8.31 (s, 1H), 7.70 (m, 2H), 7.52 (m, 2H),
7.42–7.35 (m, 5H), 7.19–7.26 (m, 5H), 5.59 (s, 1H), 4.88 (d,
J = 12.4 Hz, 1H), 4.83 (d, J = 3.2 Hz, 1H), 4.65 (d, J = 12.4 Hz, 1H),
4.43 (m, 1H), 4.08 (t, J = 9.2 Hz, 1H), 3.87 (t, J = 10.4 Hz, 1H), 3.69
(t, J = 9.2 Hz, 1H), 3.59 (m, 1H), 3.31(t, J = 8.4 Hz, 1H); 13C NMR
(100 MHz, CDCl3): 164.1, 137.0, 137.0, 134.4, 129.3, 128.8, 128.4,
128.3, 127.8, 127.7, 126.3, 102.0, 100.9, 80.9, 77.4, 77.0, 76.7,
76.6, 71.9, 71.1, 68.8, 66.3; Anal. Calcd for C27H26N2O7: C, 66.11;
H, 5.34; N, 5.71. Found: C, 66.13; H, 5.35; 5.73.
NMR (400 MHz, CDCl3): d 8.30 (s, 1H), 6.90–7.44 (m, 24H), 5.45
(s, 1H), 4.80 (d, J = 3.6 Hz, 1H), 4.82 (d, J = 6.4 Hz, 1H), 4.58 (d,
J = 8.0 Hz, 1H), 4.35–4.40 (m, 1H), 3.84–3.87 (m, 2H), 3.61–3.62
(m, 1H), 3.45 (t, J = 8.4 Hz, 1H); 13C NMR (100 MHz, CDCl3):
164.3, 144.9, 141.6, 137.1, 136.5, 134.4, 131.6, 130.7, 129.9,
129.2, 128.8, 128.4, 127.8, 127.6, 126.3, 101.5, 82.8, 77.4, 77.1,
65.5; 31P NMR (162 MHz, CDCl3): 114.9 ppm; Anal. Calcd for
C39H35N2O7P: C, 69.45; H, 5.22; N, 4.14. Found: C, 69.44; H, 5.20;
N, 4.15.
4.3. General procedure for the synthesis of carbohydrate-based
P,N ligands 10
4.3.5. Benzyl-4,6-O-benzylidene-3-O-(diphenylphosphino)-2-
deoxy-2-(2-trifluoromethylbenzylideneamino)-
10e
a-D-glucoside
To a solution of carbohydrate-based Schiff base 9 (0.5 mmol)
and a catalytic amount of 4-(dimethylamino)pyridine (10 mg) in
10 mL of degassed THF/Et3N (v/v, 4:1) was slowly added chlorodi-
phenylphosphine (0.1 mL, 0.6 mmol) at ꢀ20 °C, and the mixture
was stirred at this temperature. After 30 min, the mixture was con-
centrated to dryness and the residue was subjected to column
chromatography on Al2O3 with degassed hexane/AcOEt/Et3N (v/v,
10:1:0.1) as an eluent to give the product. The physical and spec-
troscopic data of the ligands 10a–g are as follows.
Yield (0.5 mmol, 0.280 g, 81%). ½a D20
ꢁ
¼ þ16:5 (c 0.50, CHCl3); 1H
NMR (400 MHz, CDCl3): d 8.29 (s, 1H), 6.87–7.63 (m, 24H), 5.54 (s,
1H), 4.86 (d, J = 2.4 Hz, 1H), 4.83 (d, J = 6.0 Hz, 1H), 4.66 (d,
J = 8.0 Hz, 1H), 4.28–4.32 (m, 1H), 3.84–3.90 (m, 2H), 3.62–
3.65(m, 1H), 3.46 (t, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3):
160.1, 137.1, 133.4, 131.7, 130.7, 129.9, 128.8, 128.7, 128.6,
128.3, 128.0, 127.9, 127.8, 127.7, 127.6, 127.5, 126.2, 126.1,
125.1, 125.0, 101.6, 99.5, 81.9, 79.8, 79.6, 77.4, 77.1, 77.0, 76.7,
75.6, 75.5, 69.5, 69.1, 63.4; 31P NMR (162 MHz, CDCl3):
114.2 ppm; Anal. Calcd for C27H26NO5P: C, 68.88; H, 5.05; N,
2.02. Found: C, 68.86; H, 5.04; N, 2.04.
4.3.1. Benzyl-4,6-O-benzylidene-3-O-(diphenylphosphino)-2-
deoxy-2-benzylideneamino-a-D-glucoside 10a
Yield (0.5 mmol, 0.258 g, 82%). ½a D20
ꢁ
¼ þ15:9 (c 0.36, CHCl3); 1H
4.3.6. Benzyl-4,6-O-benzylidene-3-O-(diphenylphosphino)-2-
NMR (400 MHz, CDCl3): d 8.30 (s, 1H), 6.87–7.68 (m, 25H), 5.52 (s,
1H), 4.86 (d, J = 3.6 Hz, 1H), 4.80 (d, J = 8.0 Hz, 1H), 4.57 (d,
J = 8.0 Hz, 1H), 4.41–4.44 (m, 1H), 3.84–3.87 (m, 2H), 3.65–3.67
(m, 1H), 3.52 (t, J = 7.2 Hz, 1H); 13C NMR (100 MHz, CDCl3):
162.6, 137.2, 133.4, 131.7, 131.6, 129.7, 128.6, 128.4, 128.3,
128.0, 127.7, 127.5, 127.4, 126.3, 126.5, 125.3, 125.0, 101.5, 99.9,
81.4, 79.7, 79.4, 77.2, 77.2, 77.2, 76.7, 75.3, 75.1, 69.8, 69.2, 63.0;
31P NMR (162 MHz, CDCl3): 114.5 ppm; Anal. Calcd for
deoxy-2-(3-chlorobenzylideneamino)-a-D-glucoside 10f
Yield (0.5 mmol, 0.279 g, 84%). ½a D20
ꢁ
¼ þ18:7 (c 0.56, CHCl3); 1H
NMR (400 MHz, CDCl3) d: 8.28 (s, 1H), 6.85–7.61 (m, 24H), 5.53 (s,
1H), 4.86 (d, J = 3.6 Hz, 1H), 4.84 (d, J = 8.0 Hz, 1H), 4.59 (d,
J = 8.4 Hz, 1H), 4.40–4.45 (m, 1H), 3.85–3.88 (m, 2H), 3.64–3.67
(m, 1H), 3.50 (t, J = 7.2 Hz, 1H); 13C NMR (100 MHz, CDCl3):
162.3, 137.2, 133.5, 131.9, 130.7, 129.7, 128.9, 128.8, 128.4,
128.0, 127.6, 127.7, 127.6, 127.7, 127.5, 126.4, 126.1, 125.3,
125.0, 101.7, 99.6, 81.8, 79.8, 79.4, 77.2, 77.2, 77.1, 76.8, 75.4,
75.2, 69.6, 69.0, 63.6; 31P NMR (162 MHz, CDCl3): 114.5 ppm; Anal.
Calcd for C39H35ClNO5P: C, 70.54; H, 5.30; N, 2.11. Found: C, 70.55;
H, 5.32; N, 2.10.
C39H36NO5P: C, 74.38; H, 5.75; N, 2.23; Found: C, 74.40; H, 5.76;
N, 2.22.
4.3.2. Benzyl-4,6-O-benzylidene-3-O-(diphenylphosphino)-2-
deoxy-2-(4-chlorobenzylideneamino)-a-D-glucoside 10b
Yield (0.5 mmol, 0.285 g, 86%). ½a D20
ꢁ
¼ þ20:3 (c 0.84, CHCl3); 1H
4.3.7. Benzyl-4,6-O-benzylidene-3-O-(diphenylphosphino)-2-
NMR (400 MHz, CDCl3): d 8.27 (s, 1H), 6.86–7.62 (m, 24H), 5.53 (s,
1H), 4.88 (d, J = 3.6 Hz, 1H), 4.82 (d, J = 8.0 Hz, 1H), 4.56 (d,
J = 8.0 Hz, 1H), 4.42–4.45 (m, 1H), 3.86–3.88 (m, 2H), 3.65–3.67
(m, 1H), 3.51 (t, J = 7.2 Hz, 1H); 13C NMR (100 MHz, CDCl3):
162.2, 137.1, 133.4, 131.8, 130.6, 129.6, 128.9, 128.5, 128.3,
128.2, 127.9, 127.6, 127.5, 126.4, 126.6, 125.4, 125.2, 101.6, 99.8,
81.5, 79.7, 79.4, 77.2, 77.2, 77.1, 76.7, 75.3, 75.1, 69.7, 69.0, 63.5;
31P NMR (162 MHz, CDCl3): 114.6 ppm; Anal. Calcd for
deoxy-2-(3-nitrobenzylideneamino)-a-D-glucoside 10g
Yield (0.5 mmol, 0.303 g, 90%). ½a D20
ꢁ
¼ þ21:5 (c 0.37, CHCl3). 1H
NMR (400 MHz, CDCl3): d 8.26 (s, 1H), 6.91–7.46 (m, 24H), 5.48 (s,
1H), 4.83 (d, J = 3.6 Hz, 1H), 4.80 (d, J = 6.0 Hz, 1H), 4.58 (d,
J = 11.2 Hz, 1H), 4.38–4.41 (m, 1H), 3.83–3.88 (m, 2H), 3.60–3.62
(m, 1H), 3.44 (t, J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) d:
164.2, 144.8, 141.6, 137.0, 136.6, 134.4, 131.7, 130.8, 129.8,
129.0, 128.7, 128.3, 127.9, 127.7, 126.2, 101.4, 82.9, 77.3, 77.0,
65.5; 31P NMR (162 MHz, CDCl3): 114.8 ppm; Anal. Calcd for
C39H35ClNO5P: C, 70.55; H, 5.30; N, 2.12. Found: C, 70.56; H,
5.30; N, 2.11.
C39H35N2O7P: C, 69.45; H, 5.22; N, 4.15. Found: C, 69.44; H, 5.20;
N, 4.16.
4.3.3. Benzyl-4,6-O-benzylidene-3-O-(diphenylphosphino)-2-
deoxy-2-(4-methoxybenzylideneamino)-
a
-
D
-glucoside 10c
4.4. General procedure for asymmetric allylic alkylations
Yield (0.5 mmol, 0.264 g, 80%). ½a D20
ꢁ
¼ þ13:5 (c 0.26, CHCl3); 1H
NMR (400 MHz, CDCl3): d 8.25 (s, 1H), 6.90–7.44 (m, 24H), 5.50 (s,
1 H), 4.90 (d, J = 2.4 Hz, 1H), 4.74 (d, J = 12.0 Hz, 1H), 4.51 (d,
J = 12.0 Hz, 1H), 4.21–4.23 (m, 1H), 3.88 (m, 1H), 3.69–3.78 (m,
1H), 3.45 (t, J = 8.4 Hz, 1H), 2.81 (d, J = 8.0 Hz, 1H), 2.48 (s, 3 H);
13C NMR (100 MHz, CDCl3): 161.3, 137.1, 137.17, 129.17, 128.49,
128.28, 128.04, 128.01, 126.28, 101.85, 99.18, 81.98, 77.33, 77.01,
76.68, 71.28, 69.88, 62.89, 56.06; 31P NMR (162 MHz, CDCl3):
114.5 ppm; Anal. Calcd for C40H38NO6P: C, 72.83; H, 5.80; N,
2.12. Found: C, 72.82; H, 5.81; N, 2.14.
Chiral ligand 10 (5 mol %) and [Pd(g
3-C3H5)Cl]2 (0.91 mg,
2.5 mol %) were dissolved in degassed CH2Cl2 (0.5 mL) under N2
and the solution was stirred at room temperature. After 30 min,
acetate 11 (0.25 g, 1.0 mmol) in toluene (1.5 mL) was added and
the mixture was stirred for 30 min. N,O-Bis-(trimethylsilyl)acetam-
ide (0.74 mL, 3 mmol), dimethyl malonate (0.35 mL, 3 mmol), and
KOAc (5 mg) were added to the above mixture in this order and
the mixture was stirred at this temperature. After 18 h the reaction
mixture was added to saturated NH4Cl (aq) and extracted with